Compare the Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of SAL023 and Italy-Manufactured Evenity in Healthy Subjects
Clinical trial NCT07384104 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07384104
- Sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-19
- Primary completion
- 2026-02-05
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.